Thoracic

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
External Intercostal Nerve BlockN/A1 trial
Active Trials
NCT06838026Not Yet Recruiting90Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Jerusalem PharmaceuticalsExternal Intercostal Nerve Block

Clinical Trials (1)

Total enrollment: 90 patients across 1 trials

NCT06838026Jerusalem PharmaceuticalsExternal Intercostal Nerve Block

Intercostal Nerve Block for Pain Management After Uniportal Video-assisted Thoracoscopic Surgeries

Start: May 2025Est. completion: Dec 202690 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space